PT788509E - Derivados peptidicos terapeuticos - Google Patents

Derivados peptidicos terapeuticos

Info

Publication number: PT788509E
Authority: PT; Portugal
Prior art keywords: peptide; peptidic derivatives; therapeutic peptidic; derivatives; amino
Prior art date: 1993-08-09

Application number

PT94924590T

Other languages

English (en)

Inventor

Sun Hyuk Kim

John E Taylor

Zhengxin Dong

Sylviane Moreau

Susan Riley Keyes

Original Assignee

Conseils De Rec Appl Scient S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-08-09

Filing date

1994-08-08

Publication date

2003-10-31

1994-08-08 Application filed by Conseils De Rec Appl Scient S filed Critical Conseils De Rec Appl Scient S

2003-10-31 Publication of PT788509E publication Critical patent/PT788509E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Immunology (AREA)
Virology (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Ophthalmology & Optometry (AREA)
Communicable Diseases (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)

PT94924590T 1993-08-09 1994-08-08 Derivados peptidicos terapeuticos PT788509E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10419493A	1993-08-09	1993-08-09

Publications (1)

Publication Number	Publication Date
PT788509E true PT788509E (pt)	2003-10-31

Family

ID=22299154

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT94924590T PT788509E (pt)	1993-08-09	1994-08-08	Derivados peptidicos terapeuticos
PT02026862T PT1288223E (pt)	1993-08-09	1994-08-08	Derivados de peptidos terapeuticos

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PT02026862T PT1288223E (pt)	1993-08-09	1994-08-08	Derivados de peptidos terapeuticos

Country Status (30)

Country	Link
US (1)	US5552520A (pt)
EP (3)	EP1288224B1 (pt)
JP (3)	JP3618750B2 (pt)
KR (1)	KR100325972B1 (pt)
CN (1)	CN1055700C (pt)
AT (3)	ATE241643T1 (pt)
AU (1)	AU689490B2 (pt)
CA (1)	CA2168113C (pt)
CZ (3)	CZ292586B6 (pt)
DE (3)	DE69432758T2 (pt)
DK (3)	DK1288223T3 (pt)
ES (3)	ES2229045T3 (pt)
FI (1)	FI960584A (pt)
GE (1)	GEP20002146B (pt)
HK (2)	HK1053314A1 (pt)
HU (1)	HU224350B1 (pt)
LT (1)	LT4078B (pt)
LV (1)	LV11549B (pt)
MD (1)	MD1591B2 (pt)
NZ (1)	NZ271238A (pt)
PL (1)	PL180612B1 (pt)
PT (2)	PT788509E (pt)
RO (1)	RO117259B1 (pt)
RU (1)	RU2133252C1 (pt)
SG (1)	SG75092A1 (pt)
SI (2)	SI0788509T1 (pt)
SK (1)	SK15096A3 (pt)
UA (1)	UA44707C2 (pt)
WO (1)	WO1995004752A1 (pt)
ZA (1)	ZA945966B (pt)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2774769B2 (ja) *	1993-04-26	1998-07-09	賢治寒川	アドレノメデュリン
JP3821485B2 (ja) *	1995-03-20	2006-09-13	協和醗酵工業株式会社	新規カルシトニン誘導体
US5824772A (en) *	1995-04-04	1998-10-20	Advanced Bioconcept, Inc.	Fluorescent somatostatin
US6861053B1 (en)	1999-08-11	2005-03-01	Cedars-Sinai Medical Center	Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en)	1995-05-17	2006-05-23	Cedars-Sinai Medical Center	Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6479457B2 (en)	1995-06-06	2002-11-12	Kinerton Limited	Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
US5830431A (en) *	1995-06-07	1998-11-03	Mallinckrodt Medical, Inc.	Radiolabeled peptide compositions for site-specific targeting
US6544949B1 (en)	1995-07-13	2003-04-08	Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S.	Analogs of parathyroid hormone
US7410948B2 (en)	1995-07-13	2008-08-12	Societe De Conseils De Recherches Et D'applications Scientifiques, Sas	Analogs of parathyroid hormone
US5766620A (en) *	1995-10-23	1998-06-16	Theratech, Inc.	Buccal delivery of glucagon-like insulinotropic peptides
US7078413B2 (en)	1996-04-19	2006-07-18	Wisconsin Alumni Research Foundation	Compositions and methods of use for a bombesin peptide
US6492330B1 (en) *	1996-08-16	2002-12-10	National Institute Of Immunology	Antiangiogenic drugs
US5968903A (en) *	1998-05-07	1999-10-19	Biomeasure, Incorporated	Inhibition of H. pylori proliferation
US6124263A (en) *	1998-11-16	2000-09-26	Asta Medica Ag	Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
BR0011919A (pt) *	1999-06-25	2002-03-19	Sod Conseils Rech Applic	Agonistas de somatostatina
US6864234B1 (en)	1999-06-25	2005-03-08	Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S.	Somatostatin agonists
IES990700A2 (en)	1999-08-18	2001-08-22	Kinerton Ltd	Process to make a sustained release formulation
CZ2002333A3 (cs) *	1999-08-18	2002-08-14	Societe De Conseils De Recherches Et D'application	Sloučenina 1 obsahující sloučeninu A, farmaceutický prostředek a pouľití sloučeniny A pro výrobu léčiva pro léčení chorob
EP1348444B1 (en) *	1999-08-18	2006-04-12	Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S.	Sustained release formulation of a peptide complexed with a polymer
AU2004200688B2 (en) *	1999-08-18	2007-01-25	Ipsen Pharma S.A.S.	Sustained release formulation of a peptide
US7109166B1 (en)	1999-08-18	2006-09-19	Societe De Conseils De Recherches Et D'applications Scientifiques, Sas	Sustained release formulation of a peptide
GB0018891D0 (en)	2000-08-01	2000-09-20	Novartis Ag	Organic compounds
US6316414B1 (en)	2000-07-31	2001-11-13	Dabur Research Foundation	Somatostatin analogs for the treatment of cancer
MD2074G2 (ro) *	2000-12-29	2003-06-30	Юрий НИКИТИН	Procedeu şi instalaţie de captare a vaporilor de carburant la staţiile de alimentare cu petrol, condensator al vaporilor de carburant utilizat în instalaţia menţionată
DE60232203D1 (de)	2001-03-06	2009-06-10	Il Consorzio Ferrara Richerche	Verfahren zur Modulation der Proliferation von Schilddrüsenkrebszellen
HUP0401535A3 (en) *	2001-03-08	2009-07-28	Univ Tulane	Somatostatin antagonists and their use
US20030229013A1 (en) *	2001-12-07	2003-12-11	Shih-Kwang Wu	Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same
FR2833596B1 (fr) *	2001-12-14	2005-02-18	Aventis Pharma Sa	Procede de preparation de derives d'echinocandine
US20040171070A1 (en) *	2002-05-20	2004-09-02	Ramagauri Bhikhabhai	Peptide analysis using a solid support
BR0316685A (pt)	2002-12-17	2005-11-01	Nastech Pharm Co	Composições e métodos para a administração aperfeiçoada por via mucosal de peptìdeos fixadores ao receptor de y2 e métodos para tratar e prevenir a obesidade
US7186692B2 (en)	2002-12-17	2007-03-06	Nastech Pharmaceutical Company Inc.	Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7229966B2 (en)	2002-12-17	2007-06-12	Nastech Pharmaceutical Company Inc.	Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
US7166575B2 (en)	2002-12-17	2007-01-23	Nastech Pharmaceutical Company Inc.	Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
US7772188B2 (en)	2003-01-28	2010-08-10	Ironwood Pharmaceuticals, Inc.	Methods and compositions for the treatment of gastrointestinal disorders
US20090220587A1 (en) *	2005-02-01	2009-09-03	United State Army	Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands
US7741431B2 (en) *	2005-02-01	2010-06-22	The United States Of America As Represented By The Secretary Of The Army	Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof
EP1940842B1 (en)	2005-09-29	2012-05-30	Merck Sharp & Dohme Corp.	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
EP2083831B1 (en)	2006-09-22	2013-12-25	Merck Sharp & Dohme Corp.	Method of treatment using fatty acid synthesis inhibitors
JP5649825B2 (ja)	2007-01-31	2015-01-07	デイナファーバーキャンサーインスティチュート，インコーポレイテッド	安定化させたｐ５３ペプチドおよびその使用法
CA2682174C (en)	2007-03-28	2021-04-06	President And Fellows Of Harvard College	Stitched polypeptides
AU2008233662B2 (en)	2007-04-02	2012-08-23	Msd K.K.	Indoledione derivative
ES2750651T3 (es)	2008-06-12	2020-03-26	Ipsen Bioinnovation Ltd	Proteínas de fusión para uso en el tratamiento de acromegalia
CN102083451A (zh)	2008-06-12	2011-06-01	赛恩泰新公司	癌症的抑制
GB0820970D0 (en)	2008-11-17	2008-12-24	Syntaxin Ltd	Suppression of cancer
EP2408472A4 (en) *	2009-03-18	2013-01-02	Univ Leland Stanford Junior	USE OF SOMATOSTATIN OR ANALOG IN COMBINATION WITH EXTERNAL RADIOTHERAPY
LT2462246T (lt)	2009-09-28	2017-11-27	Intarcia Therapeutics, Inc	Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
JP5892940B2 (ja)	2009-11-25	2016-03-23	アリスジェンソシエテアノニム	クラウン化合物及び／又は対イオンと複合体化されたペプチドを含む粘膜送達組成物
CA2786181C (en)	2010-01-13	2017-12-12	Ipsen Pharma S.A.S.	Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
CN102260352B (zh) *	2010-05-28	2013-11-20	山东先声麦得津生物制药有限公司	靶向性白细胞介素融合蛋白及其制备方法与应用
EP2399931A1 (fr) *	2010-06-22	2011-12-28	Ipsen Pharma S.A.S.	Nouveaux composés octapeptidiques et leur utilisation thérapeutique
PL2603600T3 (pl)	2010-08-13	2019-06-28	Aileron Therapeutics, Inc.	Makrocykle peptidomometyczne
AR088392A1 (es)	2011-10-18	2014-05-28	Aileron Therapeutics Inc	Macrociclos peptidomimeticos
RU2017145921A (ru)	2012-02-15	2019-02-21	Эйлерон Терапьютикс, Инк.	Пептидомиметические макроциклы
CN104144695A (zh)	2012-02-15	2014-11-12	爱勒让治疗公司	三唑交联的和硫醚交联的拟肽大环化合物
KR20150082307A (ko)	2012-11-01	2015-07-15	에일러론 테라퓨틱스 인코포레이티드	이치환 아미노산 및 이의 제조 및 사용 방법
SG10201902594QA (en)	2014-09-24	2019-04-29	Aileron Therapeutics Inc	Peptidomimetic macrocycles and uses thereof
KR20170129879A (ko)	2015-03-20	2017-11-27	에일러론 테라퓨틱스 인코포레이티드	펩티드모방 거대고리 및 이의 용도
EP3458084B1 (en)	2016-05-16	2020-04-01	Intarcia Therapeutics, Inc	Glucagon-receptor selective polypeptides and methods of use thereof
CN108659100A (zh) *	2017-03-28	2018-10-16	上海新生源医药集团有限公司	具有镇痛作用的多肽及其应用
AR116632A1 (es)	2018-10-11	2021-05-26	Intarcia Therapeutics Inc	Polipéptidos análogos de la amilina humana y sus métodos de uso
KR102740870B1 (ko) *	2020-08-05	2024-12-12	주식회사 레미바이오	아스코르브산 유도체 및 이를 포함하는 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1246055A (en) *	1980-03-24	1988-12-06	Joseph H. Cort	N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs
DE3522638A1 (de) *	1985-06-25	1987-01-08	Diamalt Ag	Neue somatostatin-derivate
DE3614833A1 (de)	1986-01-16	1987-07-23	Hoechst Ag	Peptide mit vasorelaxierender, natriuretischer und diuretischer wirkung, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
HU906341D0 (en) *	1986-10-13	1991-04-29	Sandoz Ag	Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
GB2218102B (en) *	1988-04-08	1992-09-16	Sandoz Ltd	Calcitonin peptide derivatives
ZA895838B (en)	1988-08-18	1991-03-27	Syntex Inc	Pharmaceutical compounds
FR2638968B1 (fr)	1988-11-11	1994-10-07	Sandoz Sa	Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives
DE69024230T2 (de) *	1989-12-22	1996-05-02	Commw Scient Ind Res Org	An fette gebundene aminosäuren, peptide oder deren derivate
GB9209032D0 (en) *	1992-04-25	1992-06-10	Ciba Geigy Ag	New peptide derivatives

1994
- 1994-08-08 PT PT94924590T patent/PT788509E/pt unknown
- 1994-08-08 CN CN94193717A patent/CN1055700C/zh not_active Expired - Fee Related
- 1994-08-08 HU HU9600281A patent/HU224350B1/hu not_active IP Right Cessation
- 1994-08-08 AT AT94924590T patent/ATE241643T1/de not_active IP Right Cessation
- 1994-08-08 RO RO96-00225A patent/RO117259B1/ro unknown
- 1994-08-08 JP JP50654195A patent/JP3618750B2/ja not_active Expired - Lifetime
- 1994-08-08 CZ CZ1996390A patent/CZ292586B6/cs not_active IP Right Cessation
- 1994-08-08 ES ES02026862T patent/ES2229045T3/es not_active Expired - Lifetime
- 1994-08-08 EP EP02026863A patent/EP1288224B1/en not_active Expired - Lifetime
- 1994-08-08 ES ES02026863T patent/ES2309131T3/es not_active Expired - Lifetime
- 1994-08-08 DE DE69432758T patent/DE69432758T2/de not_active Expired - Lifetime
- 1994-08-08 RU RU96104340A patent/RU2133252C1/ru not_active IP Right Cessation
- 1994-08-08 EP EP94924590A patent/EP0788509B1/en not_active Expired - Lifetime
- 1994-08-08 GE GEAP19943038A patent/GEP20002146B/en unknown
- 1994-08-08 CA CA002168113A patent/CA2168113C/en not_active Expired - Fee Related
- 1994-08-08 AT AT02026862T patent/ATE284413T1/de not_active IP Right Cessation
- 1994-08-08 KR KR1019960700664A patent/KR100325972B1/ko not_active IP Right Cessation
- 1994-08-08 WO PCT/US1994/008875 patent/WO1995004752A1/en active IP Right Grant
- 1994-08-08 SI SI9430451T patent/SI0788509T1/xx unknown
- 1994-08-08 AT AT02026863T patent/ATE399177T1/de not_active IP Right Cessation
- 1994-08-08 EP EP02026862A patent/EP1288223B1/en not_active Expired - Lifetime
- 1994-08-08 PL PL94312989A patent/PL180612B1/pl not_active IP Right Cessation
- 1994-08-08 DK DK02026862T patent/DK1288223T3/da active
- 1994-08-08 DK DK94924590T patent/DK0788509T3/da active
- 1994-08-08 SK SK150-96A patent/SK15096A3/sk unknown
- 1994-08-08 DE DE69435105T patent/DE69435105D1/de not_active Expired - Lifetime
- 1994-08-08 MD MD96-0137A patent/MD1591B2/ro unknown
- 1994-08-08 AU AU74819/94A patent/AU689490B2/en not_active Ceased
- 1994-08-08 SI SI9420051A patent/SI9420051A/sl unknown
- 1994-08-08 DK DK02026863T patent/DK1288224T3/da active
- 1994-08-08 PT PT02026862T patent/PT1288223E/pt unknown
- 1994-08-08 UA UA96020456A patent/UA44707C2/uk unknown
- 1994-08-08 SG SG1996005779A patent/SG75092A1/en unknown
- 1994-08-08 ES ES94924590T patent/ES2196031T3/es not_active Expired - Lifetime
- 1994-08-08 NZ NZ271238A patent/NZ271238A/en not_active IP Right Cessation
- 1994-08-08 DE DE69434181T patent/DE69434181T2/de not_active Expired - Lifetime
- 1994-08-09 US US08/287,957 patent/US5552520A/en not_active Expired - Lifetime
- 1994-08-09 ZA ZA945966A patent/ZA945966B/xx unknown
1996
- 1996-02-08 FI FI960584A patent/FI960584A/fi not_active Application Discontinuation
- 1996-03-06 LT LT96-025A patent/LT4078B/lt not_active IP Right Cessation
- 1996-03-08 LV LVP-96-71A patent/LV11549B/en unknown
2000
- 2000-03-22 CZ CZ20001033A patent/CZ289552B6/cs not_active IP Right Cessation
- 2000-03-22 CZ CZ20001032A patent/CZ289590B6/cs not_active IP Right Cessation
2003
- 2003-08-04 HK HK03105592A patent/HK1053314A1/xx not_active IP Right Cessation
- 2003-08-04 HK HK03105591A patent/HK1053313A1/xx not_active IP Right Cessation
2004
- 2004-08-12 JP JP2004235503A patent/JP3869439B2/ja not_active Expired - Lifetime
- 2004-08-12 JP JP2004235535A patent/JP3785179B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP2004339237A (ja)	2004-12-02
FI960584A0 (fi)	1996-02-08
CZ292586B6 (cs)	2003-10-15
CN1055700C (zh)	2000-08-23
ATE399177T1 (de)	2008-07-15
JP3618750B2 (ja)	2005-02-09
DE69435105D1 (de)	2008-08-07
AU7481994A (en)	1995-02-28
EP1288224A1 (en)	2003-03-05
DE69434181T2 (de)	2005-12-01
SK15096A3 (en)	1996-07-03
CA2168113C (en)	2002-10-01
SI9420051A (en)	1996-12-31
GEP20002146B (en)	2000-06-25
EP1288223B1 (en)	2004-12-08
HUT73491A (en)	1996-08-28
HU224350B1 (hu)	2005-08-29
KR100325972B1 (ko)	2002-07-27
MD1591B2 (ro)	2001-01-31
LV11549A (lv)	1996-10-20
HK1053314A1 (en)	2003-10-17
EP0788509B1 (en)	2003-05-28
DK1288224T3 (da)	2008-10-13
JP3869439B2 (ja)	2007-01-17
JP2005015488A (ja)	2005-01-20
EP0788509A4 (en)	1999-07-14
LT96025A (en)	1996-07-25
EP0788509A1 (en)	1997-08-13
ES2229045T3 (es)	2005-04-16
WO1995004752A1 (en)	1995-02-16
CZ39096A3 (en)	1996-11-13
RU2133252C1 (ru)	1999-07-20
HK1053313A1 (en)	2003-10-17
ES2309131T3 (es)	2008-12-16
PL312989A1 (en)	1996-05-27
MD960137A (en)	1999-01-31
ES2196031T3 (es)	2003-12-16
JP3785179B2 (ja)	2006-06-14
PL180612B1 (pl)	2001-03-30
DE69432758D1 (en)	2003-07-03
ATE241643T1 (de)	2003-06-15
AU689490B2 (en)	1998-04-02
CA2168113A1 (en)	1995-02-16
UA44707C2 (uk)	2002-03-15
NZ271238A (en)	1997-10-24
FI960584A (fi)	1996-02-08
JPH09501177A (ja)	1997-02-04
EP1288224B1 (en)	2008-06-25
SI0788509T1 (en)	2003-10-31
DE69434181D1 (de)	2005-01-13
CZ289590B6 (cs)	2002-02-13
CZ289552B6 (cs)	2002-02-13
EP1288223A1 (en)	2003-03-05
US5552520A (en)	1996-09-03
ATE284413T1 (de)	2004-12-15
PT1288223E (pt)	2005-03-31
CN1133047A (zh)	1996-10-09
DK0788509T3 (da)	2003-06-23
LV11549B (en)	1997-04-20
HU9600281D0 (en)	1996-04-29
ZA945966B (en)	1995-06-26
RO117259B1 (ro)	2001-12-28
DK1288223T3 (da)	2005-03-29
SG75092A1 (en)	2000-09-19
DE69432758T2 (de)	2004-02-19
LT4078B (en)	1996-12-27

Publication	Publication Date	Title
PT788509E (pt)	2003-10-31	Derivados peptidicos terapeuticos
DE69807679D1 (de)	2002-10-10	Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
ATE133181T1 (de)	1996-02-15	Dehydrodidemnin b
ES2192620T3 (es)	2003-10-16	Polipeptido receptor de il-13.
DE69613137D1 (de)	2001-07-05	Zyklische peptidanaloga von somatostatin
ATE278710T1 (de)	2004-10-15	Antimikrobiell wirksame peptide
UA32523C2 (uk)	2001-02-15	Пептиди, які мають високу біологічну активність, та фармацевтична композиція на їх основі
ES2058479T3 (es)	1994-11-01	Compuestos peptidicos.
ATE90359T1 (de)	1993-06-15	Peptide.
TR199600583A2 (tr)	1997-02-21	Farmasötik aktiviteye sahip -amino asitlerin tolere edilebilirliginin arttirilmasi.
DE3869939D1 (de)	1992-05-14	Biologisch wirksame peptide.
ATE69240T1 (de)	1991-11-15	Mitogene peptide.